Beruflich Dokumente
Kultur Dokumente
---
STOLL W A
Lysergsaure-diathyl-amid, ein Phantastikum aus der Mutterkorngruppe.
(LSD, a hallucinatory aggent from the ergot group)
Schweiz.Arch.Neur. 60 (1947).
---
STOLL W A
Ein neues, in sehr kleinen Mengen wirsames Phantastikum.
(An new hallucinatory agent, active in very small amounts)
Schweiz, Arch, Neur. 60,483 (1947).
---
DELAY J, PICHOT P
Diethylamide de l'acide d-lysergique et troubles psychiques de
l'ergotisme.
(LSD and psychic disorders in ergotism)
C.r. Soc. Biol. 145,1609 (1951)
The authors observed after 20-50 mcg. LSD euphoria with compulsive
laughter, depression, mental disorders and even slight states of
confusion. In some cases, there were visual illusions, hallucinations
resembling those caused by mescaline, disorders of synaesthesia and
posture sense. The authors find a [superficial] similarity between
the effects of LSD and the psychic symptoms observed in epidemics of
ergotism.
---
GAUSTAT H, FERRER S, CASTELIS C, LESERVE N, LUSHNAT K
Action de las diethylamid de l'acide d-lysergique (LSD-25) sur les
fonctions
psychiques et l'electroencephalogramme.
(Effect of LSD on mental functions and the EEG)
In 7 of 12 normal subjects 40-60 mcg. LSD orally produced autonomic,
psychic and EEG responses. In 4 subjects only 1 or 2 of these
responses were observed. In 1 case LSD had no effect. The effects are
considered to be an expression of neurotic hyperexcitability
(shortening of refractory period) and a reduction in the "filtering"
of impulses through nervous centers.
---
ARNOLD O H, HOFF H
Untersuchungen uber die Wirkingsweise von Lysergsaurediathylamid. (1.
Mittelung.)
(Investigations on the mode of action of LSD (1st communication))
Wein. Ztschr.Nerenh. 6,129 (1953)
---
FREDERKING W
Ueber die Verwendung von Raushdrogen (mesklan und
Lysergsaurediaethylamid) in
der Psychotherapie.
(The use of LSD and mescaline in psychotherapy)
Psyche 7,342 (1953/54)
LSD (40-60 mcg. orally) and mescaline (0.3-0.5 Gm i.m.) were used in
neurotic patients refreactory to psychoanalysis. Over 100
"intoxication" studies (including author's personal investigations).
LSD employed in 60 instances. The "intoxication", as does a dream,
exerted a therapeutic effect aiding psychoanalysis (24 cases
described). The therapeutic effect of LSD was better than that of
mescaline. Caution is required in cases of anxiety states and
suspected schizophrenia. The author strongly recommends that each
physician using LSD should, under supervision, study the effect of a
high dose of LSD himself in order to facilitate interpretation of a
patient's experiences under LSD.
---
GAMNA G, BOFANTE B, VILLATA E
Autoesperienze con LSD
(Personal studies with LSD)
Four studies were made of 10 and 50 mcg. LSD orally (by two
psychiatrists and one chaplain). The mental symptoms were relatively
few and were accompanied by sympaticotonia, neutrophilia and an
increase in gamma globulin.
---
ROUBICEK J
Toxicke a experimentali dusveni porouchy
(Toxic and experimental psychoses)
Csl.Psychiat. 56,8 (1960)
Based on previous studies, the author emphasizes the importance of
the experimental psychoses, which are provoked by LSD or Psilocybin,
for research and psychicatric therapy.
---
SAVAGE C
Variations in ego feeling induced by d-lysergic acid diethylamide
(LSD-25)
Psychoanalyt.Rev. 42:1 (1955)
---
ABRAMSON H A
Lysergic Acid Diethylamide(LSD-25): XIX. As an adjunct to brief
psychotherapy,
with special reference to ego enhancement.
J.Psychol. 41:199 (1956)
---
BERLIN L, GUTHRIE T, WIEDER A, GOODELL H, WOLFF H G
Studies in human cerebral function: the effects of mescaline and lysergic
acid on cerebral processes pertinent to creative activity.
J.Nerv & Ment.Dis. 122:487 (1955)
LSD (50 mcg.) or mescaline (400-700 mg) orally impaired the highest
integrative functions of 4 graphic artists. Drawings revealed an
unusual expansiveness and relaxation of control, both colour and line
being free and bold. (black and white illustrations). No major
difference in effect between LSD and mescaline. Similar impairment of
functions was noted in a playwright given 50 mcg LSD orally.
---
ABRAMSON H A, JARVIK M E, LEVINE A, KAUFMAN M R, HIRSH M W